BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nezametdinova VZ, Yunes RA, Dukhinova MS, Alekseeva MG, Danilenko VN. The Role of the PFNA Operon of Bifidobacteria in the Recognition of Host's Immune Signals: Prospects for the Use of the FN3 Protein in the Treatment of COVID-19. Int J Mol Sci 2021;22:9219. [PMID: 34502130 DOI: 10.3390/ijms22179219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yunes RA, Poluektova EU, Belkina TV, Danilenko VN. Lactobacilli: Legal Regulation and Prospects for New Generation Drugs. Appl Biochem Microbiol 2022;58:652-64. [DOI: 10.1134/s0003683822050179] [Reference Citation Analysis]
2 Stamoula E, Sarantidi E, Dimakopoulos V, Ainatzoglou A, Dardalas I, Papazisis G, Kontopoulou K, Anagnostopoulos AK. Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection Status. Int J Mol Sci 2022;23:10153. [PMID: 36077551 DOI: 10.3390/ijms231710153] [Reference Citation Analysis]
3 Amedei A. Editorial of Special Issue “The Interplay of Microbiome and Immune Response in Health and Diseases—2nd Edition”. IJMS 2022;23:7169. [DOI: 10.3390/ijms23137169] [Reference Citation Analysis]
4 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Averina OV, Poluektova EU, Marsova MV, Danilenko VN. Biomarkers and Utility of the Antioxidant Potential of Probiotic Lactobacilli and Bifidobacteria as Representatives of the Human Gut Microbiota. Biomedicines 2021;9:1340. [PMID: 34680457 DOI: 10.3390/biomedicines9101340] [Reference Citation Analysis]